Cell Insight – 武汉大学联合Elsevier共同推出新期刊，期待投稿！

2021-10-10 MedSci原创 MedSci原创

侠胆医心

上海中山医院医生/ 主任医师

关于我们

关于我们

Cell Insight 是一本开放获取双月刊，以打造“世界一流期刊”为目标，以“推动中国科技期刊高质量发展”为理念，重点报道生物医学领域的最新科学与技术成果。

目前梅斯医学期刊数据库已收录，点击进入：Cell Insight

编委团队

Cell Insight由中科院院士、武汉大学舒红兵教授担任主编，病毒学国家重点实验室主任、武汉大学蓝柯教授担任执行主编，由来自中国、美国、加拿大、英国、澳大利亚、日本、意大利、比利时、韩国等全球著名学术机构的40余位学者担任编委。

主编舒红兵院士与执行主编蓝柯教授

审稿流程

Cell Insight 将提供专业且快速的论文审稿流程，论文投稿一周内决定是否送审，对送审稿件在二至四周内返回审稿意见，接受稿件 1 月内在线发表，同时在微信公众号加以推送。此外，Cell Insight 还对某些高水平、存在激烈竞争的稿件提供绿色通道快速发表。

诚邀投稿

Cell Insight 将于 2022 年 1 月正式出版第一期，创刊前三年所发表的文章均免除文章出版费。在此，我们诚挚邀请广大科研人员将相关领域高影响力的创新成果投稿至此期刊。

Cell Insight期刊涵盖的领域包括但不限于：

1. Cell biology

2. Immunology

3. Microbiology

4. Cancer biology

5. Neuroscience

6. Genetics

7. Metabolism

8. Disease mechanisms

9. New technology related to biomedical research

10. Translational research

再次欢迎大家关注投稿 Cell Insight , 如果您有任何疑问，请发送电子邮件至cellinsight@whu.edu.cn 咨询。

最后附：舒红兵主编寄语

诚邀海内外同行，

成为我们的读者、作者或审稿人，

携手共建生物医学领域智慧新刊！

期刊详情：Cell Insight

版权声明：
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料，版权均属于梅斯医学所有。非经授权，任何媒体、网站或个人不得转载，授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章，或“梅斯号”自媒体发布的文章，仅系出于传递更多信息之目的，本站仅负责审核内容合规，其内容不代表本站立场，本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系，我们将立即进行删除处理。
在此留言

评论区 (8)

#插入话题

插入图片

[GetPortalCommentsPageByObjectIdResponse(id=1962612, encodeId=c10e1962612c6, content=<a href='/topic/show?id=dbe6445416' target=_blank style='color:#2F92EE;'>#CEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4454, encryptionId=dbe6445416, topicName=CEL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ff68, createdName=维他命, createdTime=Thu Dec 16 21:43:47 CST 2021, time=2021-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2007632, encodeId=ecdf200e632ed, content=<a href='/topic/show?id=0d8d66941a' target=_blank style='color:#2F92EE;'>#elsevier#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6694, encryptionId=0d8d66941a, topicName=elsevier)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=huhuaidong387, createdTime=Sat Apr 23 18:43:47 CST 2022, time=2022-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1872294, encodeId=df6f18e229472, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4459, encryptionId=fd764459a8, topicName=Cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524d95, createdName=zhaozhouchifen, createdTime=Sun Jun 19 03:43:47 CST 2022, time=2022-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077493, encodeId=9d5a10e74935e, content=<a href='/topic/show?id=50e360e90d4' target=_blank style='color:#2F92EE;'>#期刊#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60790, encryptionId=50e360e90d4, topicName=期刊)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Mon Dec 06 20:59:48 CST 2021, time=2021-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077491, encodeId=494810e7491a4, content=<a href='/topic/show?id=900160e919c' target=_blank style='color:#2F92EE;'>#期刊分区#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60791, encryptionId=900160e919c, topicName=期刊分区)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Mon Dec 06 20:59:35 CST 2021, time=2021-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059592, encodeId=3cf81059592ec, content=是, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210814/61deb584a399410ca9b720adee4e6850/71825fee35134aee90c3ed9dfe89b69f.jpg, createdBy=3cff5430616, createdName=云舒, createdTime=Mon Oct 11 22:24:12 CST 2021, time=2021-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059269, encodeId=af45105926994, content=么一卡通技术人员卡通画图板蓝根够你用, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIrrxxDxnLic8t6EAs38Qfwo6H2h6JMleIgb9OSYf6LMnVDkQEqUXWoSDWboibjhOBI9SJDTXweqQIA/132, createdBy=50aa5321359, createdName=查查佳佳, createdTime=Sun Oct 10 21:55:17 CST 2021, time=2021-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059254, encodeId=f54e1059254d6, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=92295415888, createdName=ms6000001078606107, createdTime=Sun Oct 10 21:30:00 CST 2021, time=2021-10-10, status=1, ipAttribution=)]
2021-12-16 维他命

#CEL#

75 0
[GetPortalCommentsPageByObjectIdResponse(id=1962612, encodeId=c10e1962612c6, content=<a href='/topic/show?id=dbe6445416' target=_blank style='color:#2F92EE;'>#CEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4454, encryptionId=dbe6445416, topicName=CEL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ff68, createdName=维他命, createdTime=Thu Dec 16 21:43:47 CST 2021, time=2021-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2007632, encodeId=ecdf200e632ed, content=<a href='/topic/show?id=0d8d66941a' target=_blank style='color:#2F92EE;'>#elsevier#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6694, encryptionId=0d8d66941a, topicName=elsevier)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=huhuaidong387, createdTime=Sat Apr 23 18:43:47 CST 2022, time=2022-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1872294, encodeId=df6f18e229472, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4459, encryptionId=fd764459a8, topicName=Cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524d95, createdName=zhaozhouchifen, createdTime=Sun Jun 19 03:43:47 CST 2022, time=2022-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077493, encodeId=9d5a10e74935e, content=<a href='/topic/show?id=50e360e90d4' target=_blank style='color:#2F92EE;'>#期刊#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60790, encryptionId=50e360e90d4, topicName=期刊)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Mon Dec 06 20:59:48 CST 2021, time=2021-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077491, encodeId=494810e7491a4, content=<a href='/topic/show?id=900160e919c' target=_blank style='color:#2F92EE;'>#期刊分区#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60791, encryptionId=900160e919c, topicName=期刊分区)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Mon Dec 06 20:59:35 CST 2021, time=2021-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059592, encodeId=3cf81059592ec, content=是, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210814/61deb584a399410ca9b720adee4e6850/71825fee35134aee90c3ed9dfe89b69f.jpg, createdBy=3cff5430616, createdName=云舒, createdTime=Mon Oct 11 22:24:12 CST 2021, time=2021-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059269, encodeId=af45105926994, content=么一卡通技术人员卡通画图板蓝根够你用, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIrrxxDxnLic8t6EAs38Qfwo6H2h6JMleIgb9OSYf6LMnVDkQEqUXWoSDWboibjhOBI9SJDTXweqQIA/132, createdBy=50aa5321359, createdName=查查佳佳, createdTime=Sun Oct 10 21:55:17 CST 2021, time=2021-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059254, encodeId=f54e1059254d6, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=92295415888, createdName=ms6000001078606107, createdTime=Sun Oct 10 21:30:00 CST 2021, time=2021-10-10, status=1, ipAttribution=)]
2022-04-23 huhuaidong387

#elsevier#

79 0
[GetPortalCommentsPageByObjectIdResponse(id=1962612, encodeId=c10e1962612c6, content=<a href='/topic/show?id=dbe6445416' target=_blank style='color:#2F92EE;'>#CEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4454, encryptionId=dbe6445416, topicName=CEL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ff68, createdName=维他命, createdTime=Thu Dec 16 21:43:47 CST 2021, time=2021-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2007632, encodeId=ecdf200e632ed, content=<a href='/topic/show?id=0d8d66941a' target=_blank style='color:#2F92EE;'>#elsevier#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6694, encryptionId=0d8d66941a, topicName=elsevier)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=huhuaidong387, createdTime=Sat Apr 23 18:43:47 CST 2022, time=2022-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1872294, encodeId=df6f18e229472, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4459, encryptionId=fd764459a8, topicName=Cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524d95, createdName=zhaozhouchifen, createdTime=Sun Jun 19 03:43:47 CST 2022, time=2022-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077493, encodeId=9d5a10e74935e, content=<a href='/topic/show?id=50e360e90d4' target=_blank style='color:#2F92EE;'>#期刊#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60790, encryptionId=50e360e90d4, topicName=期刊)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Mon Dec 06 20:59:48 CST 2021, time=2021-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077491, encodeId=494810e7491a4, content=<a href='/topic/show?id=900160e919c' target=_blank style='color:#2F92EE;'>#期刊分区#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60791, encryptionId=900160e919c, topicName=期刊分区)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Mon Dec 06 20:59:35 CST 2021, time=2021-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059592, encodeId=3cf81059592ec, content=是, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210814/61deb584a399410ca9b720adee4e6850/71825fee35134aee90c3ed9dfe89b69f.jpg, createdBy=3cff5430616, createdName=云舒, createdTime=Mon Oct 11 22:24:12 CST 2021, time=2021-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059269, encodeId=af45105926994, content=么一卡通技术人员卡通画图板蓝根够你用, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIrrxxDxnLic8t6EAs38Qfwo6H2h6JMleIgb9OSYf6LMnVDkQEqUXWoSDWboibjhOBI9SJDTXweqQIA/132, createdBy=50aa5321359, createdName=查查佳佳, createdTime=Sun Oct 10 21:55:17 CST 2021, time=2021-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059254, encodeId=f54e1059254d6, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=92295415888, createdName=ms6000001078606107, createdTime=Sun Oct 10 21:30:00 CST 2021, time=2021-10-10, status=1, ipAttribution=)]
2022-06-19 zhaozhouchifen

#Cell#

61 0
[GetPortalCommentsPageByObjectIdResponse(id=1962612, encodeId=c10e1962612c6, content=<a href='/topic/show?id=dbe6445416' target=_blank style='color:#2F92EE;'>#CEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4454, encryptionId=dbe6445416, topicName=CEL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ff68, createdName=维他命, createdTime=Thu Dec 16 21:43:47 CST 2021, time=2021-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2007632, encodeId=ecdf200e632ed, content=<a href='/topic/show?id=0d8d66941a' target=_blank style='color:#2F92EE;'>#elsevier#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6694, encryptionId=0d8d66941a, topicName=elsevier)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=huhuaidong387, createdTime=Sat Apr 23 18:43:47 CST 2022, time=2022-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1872294, encodeId=df6f18e229472, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4459, encryptionId=fd764459a8, topicName=Cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524d95, createdName=zhaozhouchifen, createdTime=Sun Jun 19 03:43:47 CST 2022, time=2022-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077493, encodeId=9d5a10e74935e, content=<a href='/topic/show?id=50e360e90d4' target=_blank style='color:#2F92EE;'>#期刊#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60790, encryptionId=50e360e90d4, topicName=期刊)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Mon Dec 06 20:59:48 CST 2021, time=2021-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077491, encodeId=494810e7491a4, content=<a href='/topic/show?id=900160e919c' target=_blank style='color:#2F92EE;'>#期刊分区#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60791, encryptionId=900160e919c, topicName=期刊分区)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Mon Dec 06 20:59:35 CST 2021, time=2021-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059592, encodeId=3cf81059592ec, content=是, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210814/61deb584a399410ca9b720adee4e6850/71825fee35134aee90c3ed9dfe89b69f.jpg, createdBy=3cff5430616, createdName=云舒, createdTime=Mon Oct 11 22:24:12 CST 2021, time=2021-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059269, encodeId=af45105926994, content=么一卡通技术人员卡通画图板蓝根够你用, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIrrxxDxnLic8t6EAs38Qfwo6H2h6JMleIgb9OSYf6LMnVDkQEqUXWoSDWboibjhOBI9SJDTXweqQIA/132, createdBy=50aa5321359, createdName=查查佳佳, createdTime=Sun Oct 10 21:55:17 CST 2021, time=2021-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059254, encodeId=f54e1059254d6, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=92295415888, createdName=ms6000001078606107, createdTime=Sun Oct 10 21:30:00 CST 2021, time=2021-10-10, status=1, ipAttribution=)]
2021-12-06 医者仁者

#期刊#

132 0
[GetPortalCommentsPageByObjectIdResponse(id=1962612, encodeId=c10e1962612c6, content=<a href='/topic/show?id=dbe6445416' target=_blank style='color:#2F92EE;'>#CEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4454, encryptionId=dbe6445416, topicName=CEL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ff68, createdName=维他命, createdTime=Thu Dec 16 21:43:47 CST 2021, time=2021-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2007632, encodeId=ecdf200e632ed, content=<a href='/topic/show?id=0d8d66941a' target=_blank style='color:#2F92EE;'>#elsevier#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6694, encryptionId=0d8d66941a, topicName=elsevier)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=huhuaidong387, createdTime=Sat Apr 23 18:43:47 CST 2022, time=2022-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1872294, encodeId=df6f18e229472, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4459, encryptionId=fd764459a8, topicName=Cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524d95, createdName=zhaozhouchifen, createdTime=Sun Jun 19 03:43:47 CST 2022, time=2022-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077493, encodeId=9d5a10e74935e, content=<a href='/topic/show?id=50e360e90d4' target=_blank style='color:#2F92EE;'>#期刊#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60790, encryptionId=50e360e90d4, topicName=期刊)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Mon Dec 06 20:59:48 CST 2021, time=2021-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077491, encodeId=494810e7491a4, content=<a href='/topic/show?id=900160e919c' target=_blank style='color:#2F92EE;'>#期刊分区#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60791, encryptionId=900160e919c, topicName=期刊分区)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Mon Dec 06 20:59:35 CST 2021, time=2021-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059592, encodeId=3cf81059592ec, content=是, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210814/61deb584a399410ca9b720adee4e6850/71825fee35134aee90c3ed9dfe89b69f.jpg, createdBy=3cff5430616, createdName=云舒, createdTime=Mon Oct 11 22:24:12 CST 2021, time=2021-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059269, encodeId=af45105926994, content=么一卡通技术人员卡通画图板蓝根够你用, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIrrxxDxnLic8t6EAs38Qfwo6H2h6JMleIgb9OSYf6LMnVDkQEqUXWoSDWboibjhOBI9SJDTXweqQIA/132, createdBy=50aa5321359, createdName=查查佳佳, createdTime=Sun Oct 10 21:55:17 CST 2021, time=2021-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059254, encodeId=f54e1059254d6, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=92295415888, createdName=ms6000001078606107, createdTime=Sun Oct 10 21:30:00 CST 2021, time=2021-10-10, status=1, ipAttribution=)]
2021-12-06 医者仁者

#期刊分区#

91 0
[GetPortalCommentsPageByObjectIdResponse(id=1962612, encodeId=c10e1962612c6, content=<a href='/topic/show?id=dbe6445416' target=_blank style='color:#2F92EE;'>#CEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4454, encryptionId=dbe6445416, topicName=CEL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ff68, createdName=维他命, createdTime=Thu Dec 16 21:43:47 CST 2021, time=2021-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2007632, encodeId=ecdf200e632ed, content=<a href='/topic/show?id=0d8d66941a' target=_blank style='color:#2F92EE;'>#elsevier#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6694, encryptionId=0d8d66941a, topicName=elsevier)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=huhuaidong387, createdTime=Sat Apr 23 18:43:47 CST 2022, time=2022-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1872294, encodeId=df6f18e229472, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4459, encryptionId=fd764459a8, topicName=Cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524d95, createdName=zhaozhouchifen, createdTime=Sun Jun 19 03:43:47 CST 2022, time=2022-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077493, encodeId=9d5a10e74935e, content=<a href='/topic/show?id=50e360e90d4' target=_blank style='color:#2F92EE;'>#期刊#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60790, encryptionId=50e360e90d4, topicName=期刊)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Mon Dec 06 20:59:48 CST 2021, time=2021-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077491, encodeId=494810e7491a4, content=<a href='/topic/show?id=900160e919c' target=_blank style='color:#2F92EE;'>#期刊分区#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60791, encryptionId=900160e919c, topicName=期刊分区)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Mon Dec 06 20:59:35 CST 2021, time=2021-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059592, encodeId=3cf81059592ec, content=是, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210814/61deb584a399410ca9b720adee4e6850/71825fee35134aee90c3ed9dfe89b69f.jpg, createdBy=3cff5430616, createdName=云舒, createdTime=Mon Oct 11 22:24:12 CST 2021, time=2021-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059269, encodeId=af45105926994, content=么一卡通技术人员卡通画图板蓝根够你用, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIrrxxDxnLic8t6EAs38Qfwo6H2h6JMleIgb9OSYf6LMnVDkQEqUXWoSDWboibjhOBI9SJDTXweqQIA/132, createdBy=50aa5321359, createdName=查查佳佳, createdTime=Sun Oct 10 21:55:17 CST 2021, time=2021-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059254, encodeId=f54e1059254d6, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=92295415888, createdName=ms6000001078606107, createdTime=Sun Oct 10 21:30:00 CST 2021, time=2021-10-10, status=1, ipAttribution=)]
2021-10-11 云舒

是

88 0
[GetPortalCommentsPageByObjectIdResponse(id=1962612, encodeId=c10e1962612c6, content=<a href='/topic/show?id=dbe6445416' target=_blank style='color:#2F92EE;'>#CEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4454, encryptionId=dbe6445416, topicName=CEL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ff68, createdName=维他命, createdTime=Thu Dec 16 21:43:47 CST 2021, time=2021-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2007632, encodeId=ecdf200e632ed, content=<a href='/topic/show?id=0d8d66941a' target=_blank style='color:#2F92EE;'>#elsevier#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6694, encryptionId=0d8d66941a, topicName=elsevier)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=huhuaidong387, createdTime=Sat Apr 23 18:43:47 CST 2022, time=2022-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1872294, encodeId=df6f18e229472, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4459, encryptionId=fd764459a8, topicName=Cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524d95, createdName=zhaozhouchifen, createdTime=Sun Jun 19 03:43:47 CST 2022, time=2022-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077493, encodeId=9d5a10e74935e, content=<a href='/topic/show?id=50e360e90d4' target=_blank style='color:#2F92EE;'>#期刊#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60790, encryptionId=50e360e90d4, topicName=期刊)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Mon Dec 06 20:59:48 CST 2021, time=2021-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077491, encodeId=494810e7491a4, content=<a href='/topic/show?id=900160e919c' target=_blank style='color:#2F92EE;'>#期刊分区#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60791, encryptionId=900160e919c, topicName=期刊分区)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Mon Dec 06 20:59:35 CST 2021, time=2021-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059592, encodeId=3cf81059592ec, content=是, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210814/61deb584a399410ca9b720adee4e6850/71825fee35134aee90c3ed9dfe89b69f.jpg, createdBy=3cff5430616, createdName=云舒, createdTime=Mon Oct 11 22:24:12 CST 2021, time=2021-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059269, encodeId=af45105926994, content=么一卡通技术人员卡通画图板蓝根够你用, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIrrxxDxnLic8t6EAs38Qfwo6H2h6JMleIgb9OSYf6LMnVDkQEqUXWoSDWboibjhOBI9SJDTXweqQIA/132, createdBy=50aa5321359, createdName=查查佳佳, createdTime=Sun Oct 10 21:55:17 CST 2021, time=2021-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059254, encodeId=f54e1059254d6, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=92295415888, createdName=ms6000001078606107, createdTime=Sun Oct 10 21:30:00 CST 2021, time=2021-10-10, status=1, ipAttribution=)]
2021-10-10 查查佳佳

么一卡通技术人员卡通画图板蓝根够你用

80 0
[GetPortalCommentsPageByObjectIdResponse(id=1962612, encodeId=c10e1962612c6, content=<a href='/topic/show?id=dbe6445416' target=_blank style='color:#2F92EE;'>#CEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4454, encryptionId=dbe6445416, topicName=CEL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ff68, createdName=维他命, createdTime=Thu Dec 16 21:43:47 CST 2021, time=2021-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2007632, encodeId=ecdf200e632ed, content=<a href='/topic/show?id=0d8d66941a' target=_blank style='color:#2F92EE;'>#elsevier#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6694, encryptionId=0d8d66941a, topicName=elsevier)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=huhuaidong387, createdTime=Sat Apr 23 18:43:47 CST 2022, time=2022-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1872294, encodeId=df6f18e229472, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4459, encryptionId=fd764459a8, topicName=Cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524d95, createdName=zhaozhouchifen, createdTime=Sun Jun 19 03:43:47 CST 2022, time=2022-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077493, encodeId=9d5a10e74935e, content=<a href='/topic/show?id=50e360e90d4' target=_blank style='color:#2F92EE;'>#期刊#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60790, encryptionId=50e360e90d4, topicName=期刊)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Mon Dec 06 20:59:48 CST 2021, time=2021-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077491, encodeId=494810e7491a4, content=<a href='/topic/show?id=900160e919c' target=_blank style='color:#2F92EE;'>#期刊分区#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60791, encryptionId=900160e919c, topicName=期刊分区)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Mon Dec 06 20:59:35 CST 2021, time=2021-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059592, encodeId=3cf81059592ec, content=是, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210814/61deb584a399410ca9b720adee4e6850/71825fee35134aee90c3ed9dfe89b69f.jpg, createdBy=3cff5430616, createdName=云舒, createdTime=Mon Oct 11 22:24:12 CST 2021, time=2021-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059269, encodeId=af45105926994, content=么一卡通技术人员卡通画图板蓝根够你用, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIrrxxDxnLic8t6EAs38Qfwo6H2h6JMleIgb9OSYf6LMnVDkQEqUXWoSDWboibjhOBI9SJDTXweqQIA/132, createdBy=50aa5321359, createdName=查查佳佳, createdTime=Sun Oct 10 21:55:17 CST 2021, time=2021-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059254, encodeId=f54e1059254d6, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=92295415888, createdName=ms6000001078606107, createdTime=Sun Oct 10 21:30:00 CST 2021, time=2021-10-10, status=1, ipAttribution=)]
2021-10-10 ms6000001078606107

学习学习

110 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

论文与基金

Cell Insight – 武汉大学联合Elsevier共同推出新期刊，期待投稿！

相关资讯

科室

工具

服务